Therapeutic Angiogenesis for Vascular Diseases [electronic resource] : Molecular Mechanisms and Targeted Clinical Approaches for the Treatment of Angiogenic Disease /
Slevin, Mark.editor.
Angiogenesis is the growth of new blood vessels and is a key process which occurs during pathological disease progression. Excessive and damaging angiogenesis occurs in diseases such as cancer, diabetic retinopathies, age-related macular degeneration and atherosclerosis. In other diseases such as stroke and myocardial infarction, insufficient or improper angiogenesis results in tissue loss and ultimately higher morbidity and mortality. In this book we will begin by providing the reader with an overview of the process of angiogenesis including normal embryological development of blood vessels. The following chapters will each focus on a key angiogenic disease incorporating current scientific knowledge concerning the causes of activation of the “angiogenic switch”, pathological consequences, current treatment options and future perspectives. Where appropriate, results from pre-clinical trials, novel imaging modalities and nanotechnological approaches will be incorporated into these sections. Finally, since it is now believed that the process of angiogenesis operated via different signalling mechanisms in different vascular beds, we will discuss our current understanding of this phenomenon. The target audience for this book would include researchers in all the basic sciences; post-graduate students at Universities and Institutes; pharmaceutical industries; clinicians working in vascular biology or tissue imaging; pathologists; neurologists; tumour biologists; ophthalmologists and cardiologists.
Description based upon print version of record.
Foreword; Preface; Contents; Contributors; 1 Modified 3D-Fibrin Matrices in Tissue Engineeringfor Stimulation of Angiogenesis and Wound Healing; 2 Ocular Retinopathies and Clinical Control of Angiogenesis; 3 Angiogenic Gene Therapy for the Treatment of Retinopathies; 4 Angiogenesis in Tumour Development and Metastasis; 5 Cancer Therapy by Targeting Vascular Endothelial Cell Growth Factor- and Non-Vascular Endothelial Cell Growth Factor-Mediated Angiogenesis; 6 Molecular Mechanisms of Post-Ischemic Angiogenesis in the Brain
7 Angiogenesis, the Neurovascular Niche and Neuronal Reintegration After Injury8 Safe and Effective Vascular Endothelial Cell Growth Factor (VEGF)-based Therapeutic Angiogenesis for Ischemic Stroke: Insights from Preclinical Trials; 9 Atherosclerotic Plaque Angiogenesis as a Mechanism of Intraplaque Hemorrhage and Acute Coronary Rupture; 10 Neovascularization and Intra-plaque Hemorrhage: Role of Haptoglobin, Macrophages, and Heme-Oxygenase-1 Pathway; 11 Angiogenic Approaches for Inhibition of Plaque Destabilization in Atherosclerosis
12 A Key Role of Angiogenic Control in Recovery from Ischaemic Heart Disease13 Angiogenic Mediators and the Pathogenesis of Alzheimer'sDisease; 14 Vascular Development, Stroke and Neurodegenerative Disease: A Place for Novel Clinical Interventions?; 15 Peripheral Artery Disease and Angiogenesis: A Link Between Angiogenesis and Atherothrombosis; 16 Role of Angiogenesis in the Pathogenesis of Arthritis: Potential Therapeutic Applications; 17 Angiogenesis and Giant Cell Arteritis; 18 Moyamoya Disease; 19 Overview on Nanotechnology and Angiogenesis in Major Diseases Processes; Index
Includes bibliographical references and index.
Angiogenesis is the growth of new blood vessels and is a key process which occurs during pathological disease progression. Excessive and damaging angiogenesis occurs in diseases such as cancer, diabetic retinopathies, age-related macular degeneration and atherosclerosis. In other diseases such as stroke and myocardial infarction, insufficient or improper angiogenesis results in tissue loss and ultimately higher morbidity and mortality. In this book we will begin by providing the reader with an overview of the process of angiogenesis including normal embryological development of blood vessels. The following chapters will each focus on a key angiogenic disease incorporating current scientific knowledge concerning the causes of activation of the “angiogenic switch”, pathological consequences, current treatment options and future perspectives. Where appropriate, results from pre-clinical trials, novel imaging modalities and nanotechnological approaches will be incorporated into these sections. Finally, since it is now believed that the process of angiogenesis operated via different signalling mechanisms in different vascular beds, we will discuss our current understanding of this phenomenon. The target audience for this book would include researchers in all the basic sciences; post-graduate students at Universities and Institutes; pharmaceutical industries; clinicians working in vascular biology or tissue imaging; pathologists; neurologists; tumour biologists; ophthalmologists and cardiologists.
Cancer research.
Oncology  .
Molecular biology.
Neurosciences.
Human genetics.
Cancer Research.
Oncology.
Molecular Medicine.
Neurosciences.
Human Genetics.